Pacemaker treatment for bradyarrhythmia was first approved for national health insurance
coverage in Japan in 1974, and its use rapidly became widespread thereafter …

In 2019, the Guidelines for non-pharmacotherapy of cardiac arrhythmias (JCS/JHRS 2019)
were published, covering areas such as treatment using cardiac electrical implantable …

Late-breaking clinical trials presented at the annual scientific meetings of the ACC, AHA,
HRS, and European Society of Cardiology (2008 through 2010), as well as other selected …

This revision of the “ACC/AHA/NASPE Guidelines for Implantation of Cardiac Pacemakers
and Antiarrhythmia Devices” updates the previous versions published in 1984, 1991, 1998 …

250 JCS Joint Working Group with arrhythmias not responding to the conventional
treatment. Since catheter ablation became a standard procedure in the treatment of …

Late-breaking clinical trials presented at the annual scientific meetings of the ACC, AHA,
HRS, and European Society of Cardiology (2008 through 2010), as well as other selected …

The recommendations listed in this clinical practice guideline are, whenever possible,
evidence-based. An initial extensive evidence review, which included literature derived from …

A new guideline for the management of patients with ventricular arrhythmias and the
prevention of sudden cardiac death has been published by the European Society of …

The Japanese Circulation Society (JCS) published the “Guidelines for Pharmacological
Treatment of Arrhythmia” in 2004, and a revised edition was published in 2009. 1 Both …

The online-only Data Supplement is available with this article at http://circ. ahajournals.
org/lookup/suppl/doi: 10.1161/CIR. 0b013e318276ce9b/-/DC1. The online-only …